Genomics and Personalized Medicine Act of 2006

Bill: 109-s-3822
Sponsor: Sen. Obama, Barack [D-IL]
Introduced: 2006-08-03 in the Senate
Policy area: Health
Subjects: Access to health care
Accreditation (Medical care)
Citizen participation
Civil Rights and Liberties, Minority Issues
Commerce
Communication in medicine
Congress
Congressional reporting requirements
Continuing education
Cost effectiveness
Curricula
Data banks
Deceptive advertising
Department of Health and Human Services
Discrimination in medical care
Distance education
Drug approvals
Drug industry
Drug utilization
Economics and Public Finance
Education
Environmental Protection
Environmental health
Epidemiology
Ethnic groups
Executive reorganization
Federal aid to education
Federal aid to health facilities
Finance and Financial Sector
Gene therapy
Genetic counseling
Genetic research
Genetics
Government Operations and Politics
Governmental investigations
Health information systems
Health surveys
Health warnings
Hereditary diseases
Higher education
Income tax
Labeling
Labor and Employment
Law
Licenses
Marketing
Medical economics
Medical education
Medical laboratories
Medical personnel
Medical records
Medical research
Medical residents
Medical statistics
Medical tests
Minorities
Minorities in medicine
Minority health
Mortality
Pharmaceutical research
Quality of care
Quality of life
Races
Recruiting of employees
Research and development
Right of privacy
Scholarships
Science, Technology, Communications
Standards
Tax credits
Taxation

Summary:
action_date: 2006-08-03
text: 
Genomics and Personalized Medicine Act of 2006 - Requires the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group to expand and accelerate genetics and genomics research and translate such research into clinical and public health applications; (2) expand and accelerate research and programs to collect genetic and genomic data that will advance the field of genomics and personalized medicine; (3) develop a plan for a national biobanking research initiative; (4) expand efforts to increase knowledge about the interaction between genetics and the environment and about ways in which molecular genetic screening, diagnostics, and treatments may be used to improve the health and health care of racial and ethnic minority populations; (5) increase recruitment and retention of trainees in genetics and genomics; (6) ensure the adequacy of genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (7) improve the safety, efficacy, and availability of information about genetic tests; and (8) improve the oversight and regulation of genetic tests.
 
Provides for the recruitment of health professionals from diverse backgrounds in the genomics workforce and improvement in the quality of genomics training.
 
Amends the Internal Revenue Code to establish a tax credit for qualified research expenses for the development of a qualified companion diagnostic test designed to provide information to increase the safety or effectiveness of a drug.
 
Provides for the expansion of adverse event reporting systems to encompass reports of adverse events resulting from genetic testing.


Legislative actions:
action_date: 2006-08-03
text: Read twice and referred to the Committee on Finance.
action_date: 2006-08-03
text: Sponsor introductory remarks on measure. (CR S8840-8841)
action_date: 2006-08-03
text: Introduced in Senate